Non-Opioid Pain Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Non-Opioid Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Medical Cannabis Treatment Capsaicin-derived Treatment Menthol-containing Treatment Omega 3 fatty acid-containing Treatment Botulinum Toxins Segment by Application Orthopaedic and Musculoskeletal Pain Neuropathic Pain Cancer Pain Others By Company Allergan PLC Canopy Growth Medical Marijuana Inc. Panag Pharma Inc. Tilray Aphria Inc. Bedrocan Cara Therapeutics Centrexion Therapeutics CHT Medical Cronos Group GW Pharmaceuticals Medropharm Gmbh US Worldmeds LLC By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Medical Cannabis Treatment 1.2.3 Capsaicin-derived Treatment 1.2.4 Menthol-containing Treatment 1.2.5 Omega 3 fatty acid-containing Treatment 1.2.6 Botulinum Toxins 1.3 Market by Application 1.3.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Orthopaedic and Musculoskeletal Pain 1.3.3 Neuropathic Pain 1.3.4 Cancer Pain 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Non-Opioid Pain Treatment Market Perspective (2017-2028) 2.2 Non-Opioid Pain Treatment Growth Trends by Region 2.2.1 Non-Opioid Pain Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2017-2022) 2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2023-2028) 2.3 Non-Opioid Pain Treatment Market Dynamics 2.3.1 Non-Opioid Pain Treatment Industry Trends 2.3.2 Non-Opioid Pain Treatment Market Drivers 2.3.3 Non-Opioid Pain Treatment Market Challenges 2.3.4 Non-Opioid Pain Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Non-Opioid Pain Treatment Players by Revenue 3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2017-2022) 3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue 3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio 3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2021 3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served 3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service 3.7 Date of Enter into Non-Opioid Pain Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Non-Opioid Pain Treatment Breakdown Data by Type 4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2017-2022) 4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2023-2028) 5 Non-Opioid Pain Treatment Breakdown Data by Application 5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2017-2022) 5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Non-Opioid Pain Treatment Market Size (2017-2028) 6.2 North America Non-Opioid Pain Treatment Market Size by Type 6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2017-2022) 6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2023-2028) 6.2.3 North America Non-Opioid Pain Treatment Market Share by Type (2017-2028) 6.3 North America Non-Opioid Pain Treatment Market Size by Application 6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2017-2022) 6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2023-2028) 6.3.3 North America Non-Opioid Pain Treatment Market Share by Application (2017-2028) 6.4 North America Non-Opioid Pain Treatment Market Size by Country 6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2017-2022) 6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Non-Opioid Pain Treatment Market Size (2017-2028) 7.2 Europe Non-Opioid Pain Treatment Market Size by Type 7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022) 7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2023-2028) 7.2.3 Europe Non-Opioid Pain Treatment Market Share by Type (2017-2028) 7.3 Europe Non-Opioid Pain Treatment Market Size by Application 7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022) 7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2023-2028) 7.3.3 Europe Non-Opioid Pain Treatment Market Share by Application (2017-2028) 7.4 Europe Non-Opioid Pain Treatment Market Size by Country 7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2017-2022) 7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2017-2028) 8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type 8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application 8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region 8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Non-Opioid Pain Treatment Market Size (2017-2028) 9.2 Latin America Non-Opioid Pain Treatment Market Size by Type 9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Non-Opioid Pain Treatment Market Share by Type (2017-2028) 9.3 Latin America Non-Opioid Pain Treatment Market Size by Application 9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Non-Opioid Pain Treatment Market Share by Application (2017-2028) 9.4 Latin America Non-Opioid Pain Treatment Market Size by Country 9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2017-2028) 10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type 10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application 10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country 10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan PLC 11.1.1 Allergan PLC Company Details 11.1.2 Allergan PLC Business Overview 11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction 11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.1.5 Allergan PLC Recent Developments 11.2 Canopy Growth 11.2.1 Canopy Growth Company Details 11.2.2 Canopy Growth Business Overview 11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction 11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.2.5 Canopy Growth Recent Developments 11.3 Medical Marijuana Inc. 11.3.1 Medical Marijuana Inc. Company Details 11.3.2 Medical Marijuana Inc. Business Overview 11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction 11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.3.5 Medical Marijuana Inc. Recent Developments 11.4 Panag Pharma Inc. 11.4.1 Panag Pharma Inc. Company Details 11.4.2 Panag Pharma Inc. Business Overview 11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction 11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.4.5 Panag Pharma Inc. Recent Developments 11.5 Tilray 11.5.1 Tilray Company Details 11.5.2 Tilray Business Overview 11.5.3 Tilray Non-Opioid Pain Treatment Introduction 11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.5.5 Tilray Recent Developments 11.6 Aphria Inc. 11.6.1 Aphria Inc. Company Details 11.6.2 Aphria Inc. Business Overview 11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction 11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.6.5 Aphria Inc. Recent Developments 11.7 Bedrocan 11.7.1 Bedrocan Company Details 11.7.2 Bedrocan Business Overview 11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction 11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.7.5 Bedrocan Recent Developments 11.8 Cara Therapeutics 11.8.1 Cara Therapeutics Company Details 11.8.2 Cara Therapeutics Business Overview 11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction 11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.8.5 Cara Therapeutics Recent Developments 11.9 Centrexion Therapeutics 11.9.1 Centrexion Therapeutics Company Details 11.9.2 Centrexion Therapeutics Business Overview 11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction 11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.9.5 Centrexion Therapeutics Recent Developments 11.10 CHT Medical 11.10.1 CHT Medical Company Details 11.10.2 CHT Medical Business Overview 11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction 11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.10.5 CHT Medical Recent Developments 11.11 Cronos Group 11.11.1 Cronos Group Company Details 11.11.2 Cronos Group Business Overview 11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction 11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.11.5 Cronos Group Recent Developments 11.12 GW Pharmaceuticals 11.12.1 GW Pharmaceuticals Company Details 11.12.2 GW Pharmaceuticals Business Overview 11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction 11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.12.5 GW Pharmaceuticals Recent Developments 11.13 Medropharm Gmbh 11.13.1 Medropharm Gmbh Company Details 11.13.2 Medropharm Gmbh Business Overview 11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction 11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.13.5 Medropharm Gmbh Recent Developments 11.14 US Worldmeds LLC 11.14.1 US Worldmeds LLC Company Details 11.14.2 US Worldmeds LLC Business Overview 11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction 11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) 11.14.5 US Worldmeds LLC Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Medical Cannabis Treatment Table 3. Key Players of Capsaicin-derived Treatment Table 4. Key Players of Menthol-containing Treatment Table 5. Key Players of Omega 3 fatty acid-containing Treatment Table 6. Key Players of Botulinum Toxins Table 7. Global Non-Opioid Pain Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Non-Opioid Pain Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Non-Opioid Pain Treatment Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Non-Opioid Pain Treatment Market Share by Region (2017-2022) Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Non-Opioid Pain Treatment Market Share by Region (2023-2028) Table 13. Non-Opioid Pain Treatment Market Trends Table 14. Non-Opioid Pain Treatment Market Drivers Table 15. Non-Opioid Pain Treatment Market Challenges Table 16. Non-Opioid Pain Treatment Market Restraints Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Non-Opioid Pain Treatment Revenue Share by Players (2017-2022) Table 19. Global Top Non-Opioid Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2021) Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service Table 24. Date of Enter into Non-Opioid Pain Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2017-2022) Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2023-2028) Table 30. Global Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Non-Opioid Pain Treatment Revenue Share by Application (2017-2022) Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Non-Opioid Pain Treatment Revenue Share by Application (2023-2028) Table 34. North America Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Non-Opioid Pain Treatment Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Non-Opioid Pain Treatment Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million) Table 64. Allergan PLC Company Details Table 65. Allergan PLC Business Overview Table 66. Allergan PLC Non-Opioid Pain Treatment Product Table 67. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 68. Allergan PLC Recent Developments Table 69. Canopy Growth Company Details Table 70. Canopy Growth Business Overview Table 71. Canopy Growth Non-Opioid Pain Treatment Product Table 72. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 73. Canopy Growth Recent Developments Table 74. Medical Marijuana Inc. Company Details Table 75. Medical Marijuana Inc. Business Overview Table 76. Medical Marijuana Inc. Non-Opioid Pain Treatment Product Table 77. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 78. Medical Marijuana Inc. Recent Developments Table 79. Panag Pharma Inc. Company Details Table 80. Panag Pharma Inc. Business Overview Table 81. Panag Pharma Inc. Non-Opioid Pain Treatment Product Table 82. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 83. Panag Pharma Inc. Recent Developments Table 84. Tilray Company Details Table 85. Tilray Business Overview Table 86. Tilray Non-Opioid Pain Treatment Product Table 87. Tilray Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 88. Tilray Recent Developments Table 89. Aphria Inc. Company Details Table 90. Aphria Inc. Business Overview Table 91. Aphria Inc. Non-Opioid Pain Treatment Product Table 92. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 93. Aphria Inc. Recent Developments Table 94. Bedrocan Company Details Table 95. Bedrocan Business Overview Table 96. Bedrocan Non-Opioid Pain Treatment Product Table 97. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 98. Bedrocan Recent Developments Table 99. Cara Therapeutics Company Details Table 100. Cara Therapeutics Business Overview Table 101. Cara Therapeutics Non-Opioid Pain Treatment Product Table 102. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 103. Cara Therapeutics Recent Developments Table 104. Centrexion Therapeutics Company Details Table 105. Centrexion Therapeutics Business Overview Table 106. Centrexion Therapeutics Non-Opioid Pain Treatment Product Table 107. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 108. Centrexion Therapeutics Recent Developments Table 109. CHT Medical Company Details Table 110. CHT Medical Business Overview Table 111. CHT Medical Non-Opioid Pain Treatment Product Table 112. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 113. CHT Medical Recent Developments Table 114. Cronos Group Company Details Table 115. Cronos Group Business Overview Table 116. Cronos Group Non-Opioid Pain Treatment Product Table 117. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 118. Cronos Group Recent Developments Table 119. GW Pharmaceuticals Company Details Table 120. GW Pharmaceuticals Business Overview Table 121. GW Pharmaceuticals Non-Opioid Pain Treatment Product Table 122. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 123. GW Pharmaceuticals Recent Developments Table 124. Medropharm Gmbh Company Details Table 125. Medropharm Gmbh Business Overview Table 126. Medropharm Gmbh Non-Opioid Pain Treatment Product Table 127. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 128. Medropharm Gmbh Recent Developments Table 129. US Worldmeds LLC Company Details Table 130. US Worldmeds LLC Business Overview Table 131. US Worldmeds LLC Non-Opioid Pain Treatment Product Table 132. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million) Table 133. US Worldmeds LLC Recent Developments Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2021 VS 2028 Figure 2. Medical Cannabis Treatment Features Figure 3. Capsaicin-derived Treatment Features Figure 4. Menthol-containing Treatment Features Figure 5. Omega 3 fatty acid-containing Treatment Features Figure 6. Botulinum Toxins Features Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2021 VS 2028 Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies Figure 9. Neuropathic Pain Case Studies Figure 10. Cancer Pain Case Studies Figure 11. Others Case Studies Figure 12. Non-Opioid Pain Treatment Report Years Considered Figure 13. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Non-Opioid Pain Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Non-Opioid Pain Treatment Market Share by Region: 2021 VS 2028 Figure 16. Global Non-Opioid Pain Treatment Market Share by Players in 2021 Figure 17. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2021 Figure 19. North America Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028) Figure 21. North America Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028) Figure 22. North America Non-Opioid Pain Treatment Market Size Share by Country (2017-2028) Figure 23. United States Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028) Figure 27. Europe Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028) Figure 28. Europe Non-Opioid Pain Treatment Market Size Share by Country (2017-2028) Figure 29. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Non-Opioid Pain Treatment Market Size Share by Region (2017-2028) Figure 39. China Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028) Figure 47. Latin America Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028) Figure 48. Latin America Non-Opioid Pain Treatment Market Size Share by Country (2017-2028) Figure 49. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Non-Opioid Pain Treatment Market Size Share by Country (2017-2028) Figure 55. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 59. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 60. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 61. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 62. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 63. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 64. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 65. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 66. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 67. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 68. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 69. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 70. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 71. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed